Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1987 Dec 15;137(12):1085–1087.

Poliomyelitis in North America: the disease is not dead yet.

E G Morrison 1, J A Embil 1
PMCID: PMC1267458  PMID: 3676968

Full text

PDF
1085

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almond J. W., Stanway G., Cann A. J., Westrop G. D., Evans D. M., Ferguson M., Minor P. D., Spitz M., Schild G. C. New poliovirus vaccines: a molecular approach. Vaccine. 1984 Sep;2(3):177–184. doi: 10.1016/0264-410x(84)90081-1. [DOI] [PubMed] [Google Scholar]
  2. Foote F. M., Kraus G., Andrews M. D., Hart J. C. Polio outbreak in a private school. Conn Med. 1973 Dec;37(12):643–644. [PubMed] [Google Scholar]
  3. Furesz J. Poliomyelitis outbreaks in the Netherlands and Canada. Can Med Assoc J. 1979 Apr 21;120(8):905–906. [PMC free article] [PubMed] [Google Scholar]
  4. Hovi T., Cantell K., Huovilainen A., Kinnunen E., Kuronen T., Lapinleimu K., Pöyry T., Roivainen M., Salama N., Stenvik M. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet. 1986 Jun 21;1(8495):1427–1432. doi: 10.1016/s0140-6736(86)91566-7. [DOI] [PubMed] [Google Scholar]
  5. Hughes P. J., Evans D. M., Minor P. D., Schild G. C., Almond J. W., Stanway G. The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland. J Gen Virol. 1986 Oct;67(Pt 10):2093–2102. doi: 10.1099/0022-1317-67-10-2093. [DOI] [PubMed] [Google Scholar]
  6. Lapinleimu K. Killed polio virus vaccine in the control of poliomyelitis in Finland. Ann Clin Res. 1982 Dec;14(5-6):199–203. [PubMed] [Google Scholar]
  7. Minor P. D., Evans D. M., Ferguson M., Schild G. C., Westrop G., Almond J. W. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol. 1985 May;66(Pt 5):1159–1165. doi: 10.1099/0022-1317-66-5-1159. [DOI] [PubMed] [Google Scholar]
  8. Salk J., Stoeckel P., van Wezel A. L., Lapinleimu K., van Steenis G. Antigen content of inactivated poliovirus vaccine for use in a one- or two-dose regimen. Ann Clin Res. 1982 Dec;14(5-6):204–212. [PubMed] [Google Scholar]
  9. Vukajlovich S. W., Morrison D. C. Lipid A-dependent lymphocyte proliferation in "endotoxin-nonresponder" mice. Rev Infect Dis. 1984 Jul-Aug;6(4):528–531. doi: 10.1093/clinids/6.4.528. [DOI] [PubMed] [Google Scholar]
  10. van Wezel A. L. Present state and developments in the production of inactivated poliomyelitis vaccine. Dev Biol Stand. 1981;47:7–13. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES